News

• Blood Test Predicts Treatment Response, Survival in Metastatic Di...

  Media Relations by admin June 29, 2018

  

  PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study...

  Learn More

• The PCCTC Is Expanding Its Trial Management Capabilities

  Media Relations by admin June 12, 2018

  

  To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our central management team is now s...

  Learn More

• IRONMAN: An International Registry To Improve Outcomes in Men wit...

  Press Releases by UroToday April 18, 2018

  

  PCCTC investigator Dr. Lorelei Mucci discusses innovative new registry initiative. ...

  Learn More

• PCCTC-Developed Apalutamide Gains FDA Approval

  Press Releases by admin March 9, 2018

  

  On February 14, 2018, the Food and Drug Administration (FDA) approved the next-generation AR antagonist apalutamide (Erl...

  Learn More

• PCCTC Muscadine (MPX) Study Finds Activity in Select Genotypes

  Press Releases by admin December 19, 2017

  

  A pre-planned subset analysis using a polymorphism of the superoxide dismutase-2 (SOD2) gene as a biomarker shows promis...

  Learn More

• The PCCTC Salutes Its Very Own Angie Avery

  Press Releases by admin November 7, 2017

  

  Celebrating Veterans Week 2017, we salute Angie Avery, PCCTC Project Coordinator. ...

  Learn More